TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

82 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q4 2021.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17,228,093 shares of 63,223,223 outstanding shares and own 27% of the company stock.
Largest 10 shareholders include ALLIANCEBERNSTEIN L.P. (2,454,893 shares), VANGUARD GROUP INC (2,275,779 shares), NEXT CENTURY GROWTH INVESTORS LLC (1,535,610 shares), BlackRock Inc. (1,518,826 shares), PERCEPTIVE ADVISORS LLC (980,186 shares), TimesSquare Capital Management, LLC (912,080 shares), JANUS HENDERSON GROUP PLC (666,349 shares), FMR LLC (595,700 shares), Novo Holdings A/S (500,421 shares), and Raymond James Financial Services Advisors, Inc. (469,810 shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.